by admin | Oct 2, 2025 | Announcements
At a glance Sansanima has closed a seed equity round to accelerate the rollout of human relevant, animal free testing for the manufacture of critical medicines and vaccine products. The round was supported by Sheffield Angels, o2h Ventures, and Cambridge Angels....
by admin | Oct 1, 2025 | Publications & Media Mentions
At a glance Sansanima has been recognised by Elevate as a Northern Gamechanger 2025, celebrating organisations delivering real change across the North of England. Why it matters Based in Sheffield, Sansanima is working to replace the use of animal testing in the...
by admin | Sep 2, 2025 | Publications & Media Mentions
At a glance Understanding Animal Research published a piece signposting an NC3Rs impact case study that features Sansanima’s work to remove live animal testing steps from biopharmaceutical manufacturing processes. What they reported The article points to University of...
by admin | Aug 1, 2025 | Announcements
At a glance Our CEO Ciara Doran attended the Cambridge Angels networking event, engaging with investors and founders to discuss Sansanima’s plan to replace animal testing in the manufacture of critical medicines and vaccine products. Event highlights The event brought...
by admin | Jul 2, 2025 | Announcements, Publications & Media Mentions
At a glance Thank you to everyone who voted for our CEO and Co-founder, Dr Ciara Doran, in the ClimbUK Awards 2025. We are pleased to share that Ciara has been shortlisted as a top three finalist in the Emerging Talent of the Year category. About the shortlist ClimbUK...
